← SynDRA
BLONANSERIN
SynDRA canonical compound SYN0005568 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | HTR2A |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- DRD2
- HTR2A
- ADRA1A
- DRD3
- SIGMAR1
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- Serotonin receptor antagonist
- HTR2A ANTAGONIST
- Serotonin 2a (5-HT2a) receptor antagonist
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- DRD3 ANTAGONIST
- Dopamine D3 receptor antagonist
Cross-references
Synonyms
- lonasen
- AD-5423
- Blonanserine
- Blonanserina
- DSP-5423
- Lonasen
- Blonanserin [INN]
- Blonanserin (JAN/INN)
- 2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine
- 2-(4-Ethyl-1-piperazinyl)-4-(p-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine
- 2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine
- AD 5423
- AQ316B4F8C
- DTXCID3028716
- AD5423
- blonanserinum
- RefChem:569669
- C23H30FN3
- Blonanserin (Lonasen)
- MFCD00893838
- NCGC00183858-01
- UNII-AQ316B4F8C
- BlonanserinAD-5423
- Blonanserin (Standard)
- BLONANSERIN [MI]
- BLONANSERIN [JAN]
- Blonanserin(AD-5423)
- Blonanserin (JP19/INN)
- BLONANSERIN [MART.]
- BLONANSERIN [WHO-DD]
- SCHEMBL119669
- GTPL7670
- orb1309501
- orb3141390
- SCHEMBL29379647
- Blonanserin, >=98% (HPLC)
- CHEBI:31296
- EX-A663
Look up BLONANSERIN in the interactive SynDRA portal →